Statements of Operations - USD ($)	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenues
Operating expenses:
Research and development expenses	163,405	3,390
General and administrative expenses	2,200,177	121,649
Total operating expenses	2,363,582	125,039
Loss from operations	(2,363,582)	(125,039)
Net loss before provision for income taxes	(2,363,582)	(125,039)
Provision for income taxes
Net loss	$ (2,363,582)	$ (125,039)
Net loss per common share:
Basic and diluted	$ (0.10)	$ (0.01)
Weighted average common shares outstanding:
Basic and diluted	23,541,520	22,749,087